The role of the endometrium and embryo in human implantation
… K. Diedrich 4 … (Centre of Reproductive Medicine, Dutch-speaking Brussels Free University),
Klaus Diedrich (University Hospital of Schleswig-Holstein, Lübeck, Germany), Aliza Eshkol (…
Klaus Diedrich (University Hospital of Schleswig-Holstein, Lübeck, Germany), Aliza Eshkol (…
Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review …
…, BC Tarlatzis, P Devroey, K Diedrich… - Human reproduction …, 2006 - academic.oup.com
This systematic review and meta-analysis aimed to answer the following clinical question:
among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of …
among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of …
GnRH antagonists in ovarian stimulation for IVF
…, BC Fauser, EM Kolibianakis, K Diedrich… - Human reproduction …, 2006 - academic.oup.com
The present review describes, on the basis of the currently available evidence, the
consensus reached by a group of experts on the use of gonadotropin-releasing hormone (GnRH) …
consensus reached by a group of experts on the use of gonadotropin-releasing hormone (GnRH) …
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
…, I Alvarez, L Del Mastro, O Ortmann, K Diedrich… - The Lancet, 2007 - thelancet.com
Background Early improvements in disease-free survival have been noted when an aromatase
inhibitor is given either instead of or sequentially after tamoxifen in postmenopausal …
inhibitor is given either instead of or sequentially after tamoxifen in postmenopausal …
Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation
K Diedrich, C Diedrich, E Santos, C Zoll… - Human …, 1994 - academic.oup.com
Surges of luteinizing hormone (LH) that result In luteinization but occur prematurely with
respect to the diameter of the leading folilde, prevent attempts to induce multiple follicular …
respect to the diameter of the leading folilde, prevent attempts to induce multiple follicular …
Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH) …
…, H Riethmuller-Winzen, J Engel, K Diedrich… - Human …, 2000 - academic.oup.com
In this prospective and randomized study, 188 patients received the luteinizing hormone-releasing
hormone (LHRH) antagonist cetrorelix, and 85 patients the LHRH agonist buserelin …
hormone (LHRH) antagonist cetrorelix, and 85 patients the LHRH agonist buserelin …
Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or …
…, M Ludwig, RE Felberbaum, K Diedrich… - The Journal of …, 2003 - academic.oup.com
Replacing GnRH agonist cotreatment for the prevention of a premature rise in LH during
ovarian stimulation for in vitro fertilization (IVF) by the late follicular phase administration of …
ovarian stimulation for in vitro fertilization (IVF) by the late follicular phase administration of …
Cryopreservation of human oocytes
S Al-Hasani, K Diedrich, H Van der Ven… - Human …, 1987 - academic.oup.com
Three different methods were used for freezing human excess oocytes (320 frozen, 205
thawed) in our IYF programmme and the results of these methods weax compared. A high …
thawed) in our IYF programmme and the results of these methods weax compared. A high …
A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with …
…, A Van Steirteghem, P Devroey, K Diedrich… - Human …, 2005 - academic.oup.com
BACKGROUND: Eliciting an endogenous LH surge by GnRH-agonist for the induction of
final oocyte maturation may be more physiological compared with the administration of HCG. …
final oocyte maturation may be more physiological compared with the administration of HCG. …
Over‐expression of wild‐type Rad51 correlates with histological grading of invasive ductal breast cancer
…, AC Feller, A Lopens, K Diedrich… - … journal of cancer, 2000 - Wiley Online Library
Breast cancer is a major cause of cancer‐related death in women. BRCA1 tumour‐suppressor
function is abolished in sporadic breast cancer by down‐regulation of the protein level. …
function is abolished in sporadic breast cancer by down‐regulation of the protein level. …